End-of-day quote
Taipei Exchange
03:30:00 10/05/2024 am IST
|
5-day change
|
1st Jan Change
|
55.8
TWD
|
+0.90%
|
|
-0.18%
|
-12.81%
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Capitalization
1 |
1,241
|
1,658
|
1,624
|
1,480
|
2,852
|
2,852
|
Enterprise Value (EV)
1 |
1,118
|
1,603
|
1,585
|
1,552
|
2,870
|
3,270
|
P/E ratio
|
18.7
x
|
22.1
x
|
26.2
x
|
51.3
x
|
15.9
x
|
25
x
|
Yield
|
4.85%
|
3.63%
|
2.74%
|
1.51%
|
3.28%
|
3.13%
|
Capitalization / Revenue
|
1.01
x
|
1.2
x
|
1.16
x
|
1.01
x
|
0.97
x
|
0.63
x
|
EV / Revenue
|
0.91
x
|
1.16
x
|
1.13
x
|
1.06
x
|
0.97
x
|
0.72
x
|
EV / EBITDA
|
8.29
x
|
9.94
x
|
10.9
x
|
14.4
x
|
8.98
x
|
6.15
x
|
EV / FCF
|
17.2
x
|
12.8
x
|
17.9
x
|
21.8
x
|
12.7
x
|
14.6
x
|
FCF Yield
|
5.83%
|
7.81%
|
5.58%
|
4.58%
|
7.88%
|
6.86%
|
Price to Book
|
1.2
x
|
1.58
x
|
1.54
x
|
1.43
x
|
2.38
x
|
2.59
x
|
Nbr of stocks (in thousands)
|
44,566
|
44,566
|
44,566
|
44,566
|
44,566
|
44,566
|
Reference price
2 |
27.85
|
37.20
|
36.45
|
33.20
|
64.00
|
64.00
|
Announcement Date
|
22/03/19
|
13/03/20
|
12/03/21
|
17/05/22
|
03/03/23
|
05/03/24
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net sales
1 |
1,233
|
1,380
|
1,401
|
1,465
|
2,951
|
4,543
|
EBITDA
1 |
134.8
|
161.3
|
146
|
107.7
|
319.7
|
532.2
|
EBIT
1 |
93.56
|
118.8
|
97.21
|
46.46
|
180.2
|
365.4
|
Operating Margin
|
7.59%
|
8.61%
|
6.94%
|
3.17%
|
6.1%
|
8.04%
|
Earnings before Tax (EBT)
1 |
96.16
|
119.3
|
105.7
|
61.78
|
274.9
|
310.2
|
Net income
1 |
66.68
|
75.41
|
62.05
|
28.84
|
180.2
|
114.6
|
Net margin
|
5.41%
|
5.46%
|
4.43%
|
1.97%
|
6.11%
|
2.52%
|
EPS
2 |
1.490
|
1.680
|
1.390
|
0.6471
|
4.020
|
2.560
|
Free Cash Flow
1 |
65.1
|
125.2
|
88.52
|
71.13
|
226.2
|
224.2
|
FCF margin
|
5.28%
|
9.07%
|
6.32%
|
4.86%
|
7.66%
|
4.94%
|
FCF Conversion (EBITDA)
|
48.28%
|
77.63%
|
60.62%
|
66.03%
|
70.75%
|
42.13%
|
FCF Conversion (Net income)
|
97.63%
|
166.02%
|
142.65%
|
246.63%
|
125.48%
|
195.67%
|
Dividend per Share
2 |
1.350
|
1.350
|
1.000
|
0.5000
|
2.100
|
2.000
|
Announcement Date
|
22/03/19
|
13/03/20
|
12/03/21
|
17/05/22
|
03/03/23
|
05/03/24
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net Debt
1 |
-
|
-
|
-
|
72.6
|
17.7
|
418
|
Net Cash position
1 |
124
|
55.1
|
39.3
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
-
|
-
|
-
|
0.6736
x
|
0.0554
x
|
0.7858
x
|
Free Cash Flow
1 |
65.1
|
125
|
88.5
|
71.1
|
226
|
224
|
ROE (net income / shareholders' equity)
|
7.2%
|
8.79%
|
7.57%
|
4.42%
|
16.7%
|
8.44%
|
ROA (Net income/ Total Assets)
|
3.63%
|
4.4%
|
3.49%
|
1.55%
|
4.21%
|
4.86%
|
Assets
1 |
1,839
|
1,712
|
1,780
|
1,862
|
4,285
|
2,359
|
Book Value Per Share
2 |
23.30
|
23.60
|
23.70
|
23.30
|
26.90
|
24.70
|
Cash Flow per Share
2 |
7.130
|
5.440
|
5.720
|
8.300
|
14.50
|
18.60
|
Capex
1 |
31.4
|
18.6
|
36.4
|
30.3
|
57.1
|
133
|
Capex / Sales
|
2.54%
|
1.35%
|
2.6%
|
2.07%
|
1.94%
|
2.94%
|
Announcement Date
|
22/03/19
|
13/03/20
|
12/03/21
|
17/05/22
|
03/03/23
|
05/03/24
|
|
1st Jan change
|
Capi.
|
---|
| -12.81% | 76.6M | | +9.61% | 27.43B | | -29.57% | 3.18B | | -16.08% | 2.53B | | +19.05% | 2.49B | | +11.11% | 2.16B | | -4.24% | 2.03B | | +5.56% | 1.61B | | +3.25% | 1.31B | | +29.73% | 1.29B |
Medical Supplies
|